Latest / Stock Movers / Shell Dips, Siemens Healthineers Down, Campari Plunges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move today in Europe. I'm to you added by
- 0:21Speaker 3: It with Stephen Carroll and we're joined by Bloomberg reporter
- 0:23Speaker 3: at Chloe Mallley.
- 0:25Speaker 1: So, Chloe, let's start with Shell.
- 0:26Speaker 3: It's reporting a significant profit beat. How are investors taking
- 0:30Speaker 3: the news?
- 0:31Speaker 1: Yeah, so as expected.
- 0:32Speaker 4: Just like every other oil major, Shell has massively benefited,
- 0:36Speaker 4: of course, from the surgeon oil and gas prices since
- 0:39Speaker 4: the outbreak of the Iran War, and so of course
- 0:41Speaker 4: that's been a really big boost of its oil trading
- 0:44Speaker 4: business and there has more than an offset the impact
- 0:47Speaker 4: of production cuts in the Middle East. But we are
- 0:49Speaker 4: actually seeing some weakness in the shares this morning, and
- 0:52Speaker 4: there's a few different reasons for that.
- 0:55Speaker 1: One of them is.
- 0:55Speaker 4: That expectations had been very high going into the earning
- 0:59Speaker 4: shares have been up very strongly. Another thing as well
- 1:02Speaker 4: is that the buyback has actually been cut and really
- 1:05Speaker 4: steady sholder returns are a key part of the appeal
- 1:08Speaker 4: for those oil companies, so there might be of course
- 1:11Speaker 4: some disappointment there as well. And then finally, another reason
- 1:15Speaker 4: why Shell might be a bit weaker as well this
- 1:16Speaker 4: morning is that it might be reacting to those oil
- 1:19Speaker 4: prices of falling once again after the US is said
- 1:22Speaker 4: to have presented a memo that could potentially lead to
- 1:25Speaker 4: the reopening of the Strait of Hormus, and so all
- 1:28Speaker 4: of those different things might have led to that weakness
- 1:31Speaker 4: in the ches this morning, despite actually very strong earnings
- 1:34Speaker 4: from Shell, but they were kind of expected.
- 1:36Speaker 2: Okay, So Shelle shares, as you say, lower this morning shares,
- 1:40Speaker 2: and Zeman's health and years also down about three point
- 1:42Speaker 2: six percent at the moment.
- 1:44Speaker 4: What's happened, Yeah, it's because it's cut its outlook. So
- 1:47Speaker 4: it's facing a couple of challenges. Inflation inflationary pressures is
- 1:51Speaker 4: one of them, but the main one is actually a
- 1:53Speaker 4: changing in pricing policy in China that is quite unfavorable
- 1:57Speaker 4: to its business. So it's a policy that is aimed
- 1:59Speaker 4: at lowering a healthcare costs in preventing corruption by implementing
- 2:04Speaker 4: a more centralized procurement. But for Seema's health and is,
- 2:08Speaker 4: what that's meant is that it has had the impact
- 2:10Speaker 4: of really hurting cells and its diagnostics unit, which makes
- 2:13Speaker 4: blood testing equipment, and the company did say that the
- 2:16Speaker 4: impact would be temporary. It said that the men impact
- 2:19Speaker 4: was seen in the first half of this fiscal year
- 2:22Speaker 4: and that the adjustment process would take as about four
- 2:25Speaker 4: to six quarters. But of course it has had the
- 2:29Speaker 4: impact of that. It led it to cutting its outlook
- 2:33Speaker 4: this morning. And it's worth noting as well that the
- 2:35Speaker 4: company is considering a cell of the diagnostics business anyway,
- 2:39Speaker 4: so we'll be looking at that as well.
- 2:42Speaker 1: Okay, that's Siemens.
- 2:43Speaker 3: And finally Campari is plunging this morning at what's the latest.
- 2:48Speaker 1: Yeah, down massively this morning.
- 2:49Speaker 4: Much weaker than expected results for the first quarter and
- 2:52Speaker 4: also very disappointing results of guidance for the year.
- 2:55Speaker 1: Actually, and some of.
- 2:56Speaker 4: This hip to performance was due to a time targeted
- 3:00Speaker 4: inventory optimization, that's what it called a targeted inventory optimization
- 3:05Speaker 4: in the US, which had an impact of about ten
- 3:07Speaker 4: million euros, but a lot of it was just also
- 3:10Speaker 4: generally due to really weak consumer sentiment, despite the benefit
- 3:14Speaker 4: from an earlier easter, the benefit from the winter Olympics,
- 3:18Speaker 4: although maybe people don't drink that much Apple or Sprits
- 3:20Speaker 4: training Olympics. I'm not sure, but it's been really interesting
- 3:23Speaker 4: to see what's been happening for those alcohol companies this
- 3:26Speaker 4: earning season, given we have the backdrop of inflation of
- 3:30Speaker 4: those the uptake of weight loss drugs, of a lower
- 3:32Speaker 4: alcohol consumption, but we actually saw Diadro and AB and
- 3:36Speaker 4: BEV do better than expected thanks to exposure to markets
- 3:39Speaker 4: outside of the US, of China, of Europe. And it's
- 3:42Speaker 4: actually a similar thing for Compari, where the developing markets
- 3:46Speaker 4: were doing better and outperforming whilst other markets developed markets
- 3:50Speaker 4: actually underwhelmed. So definitely an interesting trend that we can
- 3:54Speaker 4: see appear there.
- 3:55Speaker 1: But for Comparis, it's definitely not been a.
- 3:58Speaker 2: Great morning Stockmovers report from Bloomberg Radio. Check back with
- 4:04Speaker 2: us throughout the day for the latest roundup of companies
- 4:06Speaker 2: making news on Wall Street and for the latest market
- 4:09Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:14Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:17Speaker 2: the Bloomberg Business app.